BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 16476455)

  • 1. An overview of illegal opioid use and health services utilization in Canada.
    Popova S; Rehm J; Fischer B
    Public Health; 2006 Apr; 120(4):320-8. PubMed ID: 16476455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of methadone maintenance treatment utilization in a multisite cohort of illicit opioid users (OPICAN).
    Fischer B; Cruz MF; Patra J; Rehm J
    J Subst Abuse Treat; 2008 Apr; 34(3):340-6. PubMed ID: 17614236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment on "An overview of illegal opioid use and health services utilization in Canada" by S. Popova, J. Rehm, B. Fischer.
    Gatherer A
    Public Health; 2006 Nov; 120(11):1090; author reply 1091. PubMed ID: 16876214
    [No Abstract]   [Full Text] [Related]  

  • 4. The prevalence of mental and physical health disorders among older methadone patients.
    Rosen D; Smith ML; Reynolds CF
    Am J Geriatr Psychiatry; 2008 Jun; 16(6):488-97. PubMed ID: 18515693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fentanyl use among street drug users in Toronto, Canada: behavioural dynamics and public health implications.
    Firestone M; Goldman B; Fischer B
    Int J Drug Policy; 2009 Jan; 20(1):90-2. PubMed ID: 18508256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and trends of non-medical opioid and other drug use histories among federal correctional inmates in methadone maintenance treatment in Canada.
    Johnson S; MacDonald SF; Cheverie M; Myrick C; Fischer B
    Drug Alcohol Depend; 2012 Jul; 124(1-2):172-6. PubMed ID: 22265193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing overdose mortality associated with methadone and buprenorphine treatment.
    Bell JR; Butler B; Lawrance A; Batey R; Salmelainen P
    Drug Alcohol Depend; 2009 Sep; 104(1-2):73-7. PubMed ID: 19443138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
    Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A
    Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Illegal drug-attributable morbidity in Canada 2002.
    Popova S; Rehm J; Patra J; Baliunas D; Taylor B
    Drug Alcohol Rev; 2007 May; 26(3):251-63. PubMed ID: 17454014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT; Tait RJ; Hulse GK
    Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved.
    Degenhardt L; Randall D; Hall W; Law M; Butler T; Burns L
    Drug Alcohol Depend; 2009 Nov; 105(1-2):9-15. PubMed ID: 19608355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crack across Canada: Comparing crack users and crack non-users in a Canadian multi-city cohort of illicit opioid users.
    Fischer B; Rehm J; Patra J; Kalousek K; Haydon E; Tyndall M; El-Guebaly N
    Addiction; 2006 Dec; 101(12):1760-70. PubMed ID: 17156175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzodiazepine prescription for patients in opioid maintenance treatment in Norway.
    Bramness JG; Kornør H
    Drug Alcohol Depend; 2007 Oct; 90(2-3):203-9. PubMed ID: 17478058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A qualitative inquiry into methadone maintenance treatment for opioid-dependent prisoners in Tehran, Iran.
    Zamani S; Farnia M; Tavakoli S; Gholizadeh M; Nazari M; Seddighi AA; Setayesh H; Afshar P; Kihara M
    Int J Drug Policy; 2010 May; 21(3):167-72. PubMed ID: 19395250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of methadone maintenance on health utility, health care utilization and expenditure in drug users with HIV/AIDS.
    Tran BX; Nguyen LT
    Int J Drug Policy; 2013 Nov; 24(6):e105-10. PubMed ID: 23937854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting the outcome of methadone maintenance treatment in opiate dependence.
    Kamal F; Flavin S; Campbell F; Behan C; Fagan J; Smyth R
    Ir Med J; 2007 Mar; 100(3):393-7. PubMed ID: 17491538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription opioid abuse among enrollees into methadone maintenance treatment.
    Rosenblum A; Parrino M; Schnoll SH; Fong C; Maxwell C; Cleland CM; Magura S; Haddox JD
    Drug Alcohol Depend; 2007 Sep; 90(1):64-71. PubMed ID: 17386981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A primary care/multidisciplinary harm reduction clinic including opiate bridging.
    Ross D; Lo F; McKim R; Allan GM
    Subst Use Misuse; 2008; 43(11):1628-39. PubMed ID: 18752164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality among opiate users: opioid maintenance therapy, age and causes of death.
    Clausen T; Waal H; Thoresen M; Gossop M
    Addiction; 2009 Aug; 104(8):1356-62. PubMed ID: 19426288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.